Effective September 26, 2012, AtriCure, Inc. (the "Company") and Silicon Valley Bank (the "Bank") entered into a Fourth Loan Modification Agreement (the "Loan Modification Agreement") which sets forth certain amendments to the Company's credit facility with the Bank.

The Loan Modification Agreement eliminates the restriction on investments by the Company in its wholly owned subsidiary, AtriCure Europe, B.V. ("AtriCure Europe"). In connection with the Loan Modification Agreement, AtriCure Europe executed certain guaranty and security documents pursuant to which AtriCure Europe guaranteed the Company's obligations under the credit facility and pledged certain of its assets as security for the credit facility.

The foregoing description of the Loan Modification Agreement is qualified in its entirety by the full text of the Loan Modification Agreement as attached to and filed with this Form 8-K as Exhibit 10.1.

The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

(d) Exhibits.

No.     Description

10.1    Fourth Loan Modification Agreement between Silicon Valley Bank and
        AtriCure, Inc. dated September 26, 2012